Results revealed that E2F1 was involved in the HRR mechanism by regulating the expression of RAD54L. In addition, a group of bladder cancer patients with high expression of RAD54L had worse prognosis for cancer progression, suggesting that RAD54L in addition to E2F1 is a new biomarker for cancer progression. This evidence concerns the gene RAD54L and urinary bladder cancer.